Вы находитесь на странице: 1из 2

Frekuensi

Amerika Serikat
Tingkat prevalensi hiperurisemia asimtomatik dalam populasi umum diperkirakan pada 2-13%.
Internasional
Di seluruh dunia, prevalensi hiperurisemia telah meningkat secara substansial dalam akhir decade ini. Telah terjadi
peningkatan yang secara progressif dalam kadar serum asam urat yang berkaitan dengan kelebihan berat badan
dan obesitas, sama seperti peningkatan konsumsi minuman manis , makanan tinggi purines dan alkohol.

12, 13

Suatu studi Jepang telah mengumpulkan data dalam sepuluh tahun terakhir tentang prevalensi , disana didapatkan
hasil dan menyimpulkan bahwa hiperurisemia dalam populasi secara keseluruhanmeningkat selama 10 tahun
terakhir.Ketika dikelompokan berdasarkan umur prevalensi paling meningkat pada kelompok > 65 tahun tanpa
pengaruh dari jenis kelamin . < 65 tahun, prevalensi pada pria empat kali lebih tinggi dari perempuan, tetapi pada yg
berumur > 65 tahun,rasio wanita : pria adalah 1:3 dengan gout dan hiperurisemia.

Qazi Y, Batuman V, Lohr JW. Hyperuricemia.

1.

Wang YL, Zeng C, Wei J, Yang T, Li H, Deng ZH, et al. Association between Dietary Magnesium Intake
and Hyperuricemia. PLoS One. 2015. 10 (11):e0141079. [Medline].

2.

Desideri G, Puig JG, Richette P. The management of hyperuricemia with urate deposition. Curr Med
Res Opin. 2015 Sep. 31 Suppl 2:27-32. [Medline].

3.

Meneses-Leon J, Denova-Gutirrez E, Castan-Robles S, Granados-Garca V, Talavera JO, RiveraParedez B, et al. Sweetened beverage consumption and the risk of hyperuricemia in Mexican adults: a
cross-sectional study. BMC Public Health. 2014 May 12. 14:445. [Medline].

Contributor Information and Disclosures


Author
Yasir Qazi, MD Assistant Professor of Medicine, Division of Nephrology, University of Southern California at
Keck School of Medicine
Yasir Qazi, MD is a member of the following medical societies: American Society of Nephrology
Disclosure: Nothing to disclose.

Coauthor(s)
James W Lohr, MD Professor, Department of Internal Medicine, Division of Nephrology, Fellowship Program
Director, University of Buffalo State University of New York School of Medicine and Biomedical Sciences
James W Lohr, MD is a member of the following medical societies: American College of Physicians,American
Heart Association, American Society of Nephrology, Central Society for Clinical and Translational Research
Disclosure: Partner received salary from Alexion for employment.

Specialty Editor Board

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center
College of Pharmacy; Editor-in-Chief, Medscape Drug Reference
Disclosure: Received salary from Medscape for employment. for: Medscape.
George R Aronoff, MD Director, Professor, Departments of Internal Medicine and Pharmacology, Section of
Nephrology, Kidney Disease Program, University of Louisville School of Medicine
George R Aronoff, MD is a member of the following medical societies: American Federation for Medical
Research, American Society of Nephrology, Kentucky Medical Association, National Kidney Foundation
Disclosure: Nothing to disclose.

Chief Editor
Vecihi Batuman, MD, FASN Huberwald Professor of Medicine, Section of Nephrology-Hypertension, Tulane
University School of Medicine; Chief, Renal Section, Southeast Louisiana Veterans Health Care System
Vecihi Batuman, MD, FASN is a member of the following medical societies: American College of
Physicians, American Society of Hypertension, American Society of Nephrology, International Society of
Nephrology, Southern Society for Clinical Investigation
Disclosure: Nothing to disclose.

Additional Contributors
James H Sondheimer, MD, FACP, FASN Associate Professor of Medicine, Wayne State University School of
Medicine; Medical Director of Hemodialysis, Harper University Hospital at Detroit Medical Center; Medical
Director, DaVita Greenview Dialysis (Southfield)
James H Sondheimer, MD, FACP, FASN is a member of the following medical societies: American College of
Physicians, American Society of Nephrology
Disclosure: Receive dialysis unit medical director fee (as independ ent contractor) for: DaVita .

Вам также может понравиться